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Summary
Pseudomonas aeruginosa causes chronic lung infections in the airways of cystic fibrosis (CF) 
patients. Psl is an extracellular polysaccharide expressed by non-mucoid P. aeruginosa strains, 
which are believed to be initial colonizers. We hypothesized that Psl protects P. aeruginosa from 
host defences within the CF lung prior to their conversion to the mucoid phenotype. We 
discovered that serum opsonization significantly increased the production of reactive oxygen 
species (ROS) by neutrophils exposed to a psl-deficient mutant, compared with wild-type (WT) 
and Psl overexpressing strains (Psl++). Psl-deficient P. aeruginosa were internalized and killed by 
neutrophils and macrophages more efficiently than WT and Psl++ variants. Deposition of 
complement components C3, C5 and C7 was significantly higher on psl-deficient strains 
compared with WT and Psl++ bacteria. In an in vivo pulmonary competition assay, there was a 4.5-
fold fitness advantage for WT over psl-deficient P. aeruginosa. Together, these data show that Psl 
inhibits efficient opsonization, resulting in reduced neutrophil ROS production, and decreased 
killing by phagocytes. This provides a survival advantage in vivo. Since phagocytes are critical in 
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early recognition and control of infection, therapies aimed at Psl could improve the quality of life 
for patients colonized with P. aeruginosa.
Introduction
Pseudomonas aeruginosa is a versatile opportunistic pathogen that can cause chronic 
pulmonary infection in cystic fibrosis (CF) patients and is also a significant cause of disease 
in immune-compromised patients (Lyczak et al., 2002). The ability of P. aeruginosa to form 
biofilms that are recalcitrant to treatment is a major cause of mortality and morbidity in 
these patients. Neutrophils are the first phagocytic cells mobilized to clear pathogenic 
bacteria during lung infection, yet pulmonary infection in CF is complicated by the robust 
recruitment, activation and damage caused by these cells (Walker et al., 2005). During 
colonization and infection of the CF airway, P. aeruginosa undergoes phenotypic 
conversion from a non-mucoid to mucoid morphology. This phenotype is due to the 
overproduction of alginate, a capsular polysaccharide that confers a selective advantage for 
P. aeruginosa. Alginate produced by mucoid P. aeruginosa scavenges bactericidal reactive 
oxygen species (ROS), and interferes with complement activation, chemotaxis, and 
neutrophil and macrophage phagocytic killing (Learn et al., 1987; Pedersen et al., 1990; Mai 
et al., 1993; Leid et al., 2005). However, in most CF patients, mucoid conversion occurs 
months or years after initial colonization (Govan and Deretic, 1996). There remain 
significant gaps in our understanding of how P. aeruginosa survives the inflammatory-rich 
environment of the CF lung prior to converting to the alginate-producing phenotype.
Psl is a recently discovered exopolysaccharide (EPS) of non-mucoid P. aeruginosa and the 
genes encoding this EPS are highly conserved among P. aeruginosa isolates (Wolfgang et 
al., 2003). Psl is composed of repeating pentasaccharide units of D-mannose, D-glucose and L-
rhamnose (Byrd et al., 2009). Psl is critical for biofilm formation and believed to be 
expressed in P. aeruginosa isolates that are the first to colonize CF patients (Jackson et al., 
2004; Ma et al., 2006). This implies that during initial infection, biofilm formation and Psl 
synthesis likely precede the switch to mucoidy. Polysaccharides in several pathogenic 
bacteria can promote phagocyte evasion by modulating deposition of complement or 
antibody on the microbe’s surface (Clay et al., 2008; Goebel et al., 2008). However, there 
have been no studies investigating if P. aeruginosa Psl modulates interactions with cells of 
the innate immune system.
We focused our study on neutrophils and complement since these innate immune effectors 
are critical in host defence against P. aeruginosa (Jesaitis et al., 2003; Mueller-Ortiz et al., 
2004). Neutrophils are recruited early in infection and directly kill invading bacteria using 
both oxidative and non-oxidative mechanisms. The complement system is a highly regulated 
and multifunctional pathway that promotes recognition of pathogens by innate immune cells 
and is also capable of direct bacterial killing upon insertion of the terminal membrane attack 
complex (MAC). Opsonization by complement is a central mechanism for bacterial 
clearance and is crucial for maintaining mucosal immunity against infection (Gross et al., 
1978). Once bacteria are taken up by neutrophils, the subsequent oxidative burst leads to the 
production of toxic ROS (Kanegasaki, 1986; Nauseef, 2007). The processes of 
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degranulation, phagocytosis and oxidative killing furnish the neutrophil with a varied 
arsenal of antimicrobial effectors that are critical for an effective innate immune response.
A central hypothesis in the present study is that surface-bound Psl impairs phagocytosis by 
reducing complement-mediated opsonization. To test this, we utilized a collection of 
isogenic P. aeruginosa strains expressing variable amounts of surface Psl polysaccharide. 
Compared with WT bacteria, P. aeruginosa lacking Psl demonstrated increased 
complement-mediated opsonization. Lack of Psl expression led to enhanced uptake, 
oxidative burst response, and reduced intracellular bacterial survival in phagocytic cells. The 
presence of Psl provided P. aeruginosa a fitness advantage over psl mutants in an acute 
murine pulmonary model of infection. Enzymatic degradation of surface Psl also resulted in 
increased complement deposition, suggesting that pharmacological agents aimed at reducing 
Psl levels may enhance recognition and clearance of P. aeruginosa by innate immune 
effectors.
Results
Both serum opsonins and Psl polysaccharide affect the oxidative burst response 
generated by human neutrophils
To determine if Psl affects the oxidative burst response generated by human neutrophils, we 
used three isogenic P. aeruginosa strains previously developed (Ma et al., 2006) including 
WFPA801, an inducible Psl overexpressing variant, the psl-deficient strain WFPA800, and 
WT strain PAO1. Psl expression by these strains was verified with an immunoblot of surface 
extracted polysaccharide (Fig. 1A). To measure the oxidative burst response generated by 
human neutrophils towards these P. aeruginosa strains, we incubated fresh serum-opsonized 
bacteria with human neutrophils in the presence of luminol and monitored the oxidative 
burst over time (Fig. 1B). Luminol is known to react with both extra- and intracellular 
superoxide anions generated by neutrophils (Briheim et al., 1984). Kinetic analyses of 
neutrophils exposed to serum-opsonized psl mutants showed a more rapid and robust 
oxidative burst response compared with neutrophils incubated with equivalent numbers of 
WT or Psl overexpressing strains (Fig. 1B). The highest oxidative burst response was 
observed at 25 min. Therefore, this time point was chosen for comparing the response of 
neutrophils exposed to bacteria under serum-opsonized (NHS), unopsonized and heat-
inactivated serum (HIS) opsonized conditions (Fig. 1C). The oxidative burst response of 
neutrophils exposed to serum-opsonized WT, psl mutant and a Psl overexpressing P. 
aeruginosa strain was significantly higher compared with non-opsonized strains (Fig. 1C). 
Furthermore, there was a significant reduction but not elimination of the oxidative burst 
response generated by neutrophils incubated with P. aeruginosa opsonized with HIS, which 
is devoid of complement activity (Fig. 1C). These studies were also performed utilizing the 
fluorescence probe dichlorohydro-fluorescein (DCF) to detect ROS and similar results were 
observed (data not shown). This suggests that serum opsonins (both complement and 
immunoglobulin) and the Psl status significantly affect the activity of neutrophils, which are 
critical in the innate immune responses towards P. aeruginosa. The remainder of this study 
focused only on the contribution of complement as the opsonin.
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We previously showed that some Psl is released from cells during growth of P. aeruginosa 
(Byrd et al., 2009). One potential explanation for the results in Fig. 1 is that released Psl 
may be directly inhibiting the oxidative burst of neutrophils. This is the case for EPS 
produced by Burkholderia cenocepacia (Bylund et al., 2006). However, there was no 
significant difference in the oxidative burst response of neutrophils stimulated with phorbol 
myristate acetate (PMA) either in the presence or absence of purified Psl (Fig. S1). This 
suggests that Psl is not sufficient to inhibit neutrophil activation.
The presence of Psl reduces opsonophagocytosis of P. aeruginosa by human innate 
immune cells
As outlined in Fig. 1, the presence of Psl limits the oxidative burst response by neutrophils. 
We reasoned that these differential burst responses might be due to differences in the 
phagocytosis of P. aeruginosa strains. To evaluate this, serum opsonized P. aeruginosa WT 
and psl-deficient strains were incubated with human neutrophils and THP-1 derived 
macrophages. THP-1 macrophages have been frequently used to study bacterial 
internalization (Longhi et al., 2004; Ferrer et al., 2010). Unattached bacteria were removed 
by washing extensively and bacterial association and internalization assessed by differential 
immunofluorescence staining (see Experimental procedures). The amount of psl-defective 
bacteria taken up by THP-1 macrophages was 4.5-fold higher compared with that of the WT 
strain (Fig. 2A). In human neutrophils, there was an approximately threefold higher number 
of psl-deficient P. aeruginosa internalized when compared with WT bacteria (Fig. 2B). 
Thus, the increased phagocytosis of the psl-deficient strain correlates well with the increased 
oxidative burst observed when neutrophils are exposed to the same mutant strain.
The presence of Psl inhibits deposition of complement component C3, C5 and C7 on the P. 
aeruginosa surface
The activation of complement can cause direct lysis of bacteria or increase 
opsonophagocytosis (Pangburn and Muller-Eberhard, 1980; van Lookeren Campagne et al., 
2007; Clay et al., 2008). Data in Fig. 1C show that opsonization of P. aeruginosa with heat-
inactivated human serum reduced the oxidative burst response relative to fresh human 
serum, indicating a significant contribution of complement in the recognition of P. 
aeruginosa bacteria by neutrophils. We subsequently evaluated the effect of Psl on 
deposition of complement component C3, which promotes opsonization and is central to all 
three complement cascade pathways (Pangburn and Muller-Eberhard, 1980). P. aeruginosa 
strains were opsonized and C3 deposition was evaluated by flow cytometry. There was a 
significant increase in C3 deposition on psl-deficient P. aeruginosa compared with WT and 
Psl overexpressing strains (Fig. 3A). Following a 5 min opsonization period, C3 
complement deposition on psl-deficient P. aeruginosa was increased 2.1 ± 0.34- and 4.1 ± 
0.28-fold, compared with WT and Psl overexpressing bacteria respectively. C3 deposition 
on psl-deficient P. aeruginosa was also significantly higher compared with WT and Psl 
overexpressing P. aeruginosa after 20 min of opsonization (Fig. 3A).
We confirmed enhanced C3 deposition on serum opsonized psl-deficient P. aeruginosa 
compared with WT strains using immunogold transmission electron microscopy (TEM). 
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These data also revealed C3 deposition on the psl-deficient P. aeruginosa surface was 
elevated threefold compared with C3 binding to WT bacteria (Fig. 3B).
While one role of complement is to facilitate opsonophagocytosis, complement components 
also can directly kill bacteria through generation of the membrane attack complex (MAC), 
which requires complement components C5-C9. To examine the effect of Psl on 
complement components associated with the terminal lytic pathway, C5 and C7 deposition 
was evaluated. When opsonized for 20 min, C5 and C7 deposition was significantly higher 
on psl-deficient P. aeruginosa compared with WT and Psl over-expressing strains (Fig. 4A 
and B respectively). Increased C5 deposition occurred as early as 5 min, similar to the 
results with C3 and thus highlighting the rapid kinetics of complement activation on the psl-
deficient strain. C7 deposition was somewhat delayed (Fig. 4B). Since complement 
deposition occurs sequentially, the observed increase in C5 and C7 binding on Psl-deficient 
P. aeruginosa (Fig. 4A and B) is likely due to the fact that C3 deposition was elevated on 
these bacteria.
We next examined the binding of C9 to P. aeruginosa strains. Although C5b, C6, C7, C8 
and C9 are necessary for forming the MAC complex, the multimeric form of C9 is involved 
in the actual disruption of the phospholipid membrane (Inoue and Yonemasu, 1968; 
Goldman et al., 1969; Schreiber et al., 1979; Joiner et al., 1985). In contrast to C3, C5 and 
C7 deposition, we found little difference in the amount of C9 bound to P. aeruginosa WT, 
psl-deficient, or Psl overexpressing strains (Fig. 5A), suggesting that differences observed in 
upstream complement components do not translate into increased C9 deposition on psl-
deficient cells.
C9 assembly on the surface of bacteria is essential for MAC formation and serum-mediated 
killing (Joiner et al., 1985). To test whether the presence of Psl affected serum-mediated 
killing, a bacterial survival assay was performed in the presence of fresh human serum. We 
also included an LPS O-antigen-deficient P. aeruginosa strain (ΔwaaL) as a control since an 
intact O-antigen is necessary for serum resistance (Hancock et al., 1983). Addition of 
normal human serum at two concentrations (20% and 50%) failed to kill WT or any of the 
Psl variant strains (Fig. 5B). As expected, P. aeruginosa ΔwaaL was more serum sensitive 
than the parental strain. These results indicate little role for Psl in promoting serum 
resistance.
Disruption of Psl by addition of exogenous cellulase increases C3 complement binding on 
the bacterial surface
Since psl mutants are more efficiently opsonized and taken up by phagocytes than are WT 
P. aeruginosa, agents aimed at removal of Psl may promote clearance of these bacteria 
during infection. As a proof of principle we utilized cellulase, which disrupts β1–3 and β1–4 
linkages in Psl (Ma et al., 2009), and examined the effect on C3 binding. Bacteria were left 
untreated or treated with cellulase, extensively washed, opsonized and C3 binding examined 
(see Experimental procedures). When opsonized for 5 min, cellulase-treated WT bacteria 
exhibited a 10-fold increase in C3 binding on the surface compared with untreated cells. WT 
P. aeruginosa treated with phosphate-buffered saline (PBS) or PBS + cellulase showed 6.31 
± 2.58% and 66.78 ± 0.66% C3 complement deposition respectively. This effect was 
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reduced but still significant with longer opsonization times, indicating that either cellulase 
did not remove all Psl or that C3 binding at later time points becomes saturated. Importantly, 
treatment of the psl-deficient strain with cellulase did not further increase C3 binding (Δpsl 
with PBS or PBS + cellulose showed 58.49 ± 12% and 69.57 ± 2.7% C3 deposition 
respectively). This suggests that Psl is the primary cell surface molecule targeted by 
cellulase.
Psl promotes the intracellular survival of P. aeruginosa
To study the role of Psl in protection of bacteria from neutrophil killing, we incubated 
normal serum opsonized WT and psl-deficient strains of P. aeruginosa with human 
neutrophils and performed a gentamicin survival assay (see Experimental procedures). 
Compared with the WT and Psl overexpressing strains, there was an eightfold reduction in 
intracellular survival of psl mutants (Fig. 6A). We reasoned that this reduced survival of psl 
mutants in neutrophils was likely due to their increased opsonophagocytosis, and more 
intense oxidative burst compared with that generated in response to WT bacteria. To address 
any potential additional role for Psl in protection from intracellular killing by neutrophils, 
we normalized the bacterial uptake in neutrophils by adjusting the multiplicity of infection 
(moi) of WT and psl-deficient P. aeruginosa and repeated the intracellular killing assay as 
above. Under these conditions, equivalent numbers of WT and psl mutant bacteria were 
taken up by neutrophils (Fig. 6B). Our result revealed that WT P. aeruginosa bacteria had a 
sixfold increase in survival compared with the psl-deficient strain (Fig. 6A). These data 
indicate an additional role for Psl in providing protection of bacteria from intracellular 
neutrophil-mediated killing.
The presence of Psl provides a fitness advantage for P. aeruginosa during an acute 
murine pulmonary infection
Since Psl appears to limit ospsonophagocytosis and promotes intracellular survival in 
neutrophils, we designed a study to determine if WT P. aeruginosa had an in vivo fitness 
advantage compared with a psl-deficient strain. Mice were co-infected intranasally with a 
1:1 mixture of isogenic WT and psl-deficient strains of P. aeruginosa. These bacteria were 
distinguished based on differential antibiotic susceptibility (see Experimental procedures). 
At 4 and 12 h post infection mice were sacrificed and the bacterial burden was enumerated 
from the lung homogenate. The mean competitive index (CI) value was 1.2 at 4 h post 
infection, indicating similar delivery of both WT and psl mutants. However, this declined to 
0.3 at 12 h post infection, indicating that psl-deficient bacteria had a significantly reduced 
fitness advantage in the lungs of mice when co-infected with WT strains. An in vitro growth 
competition experiment with co-culturing PAO1 Smr and psl-deficient bacteria did not show 
a growth advantage for either strain with a CI value of 1.0. These results support the 
conclusion that Psl contributes to protection of P. aeruginosa from innate immune cells.
Discussion
Psl polysaccharide plays a crucial role in initial attachment and biofilm formation by non-
mucoid P. aeruginosa strains (Friedman and Kolter, 2004; Jackson et al., 2004; Matsukawa 
and Greenberg, 2004). Non-mucoid, Psl-expressing bacteria are believed to be the first to 
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colonize the CF airway and are challenged with a harsh inflammatory- and neutrophil-rich 
lung environment. There have been no studies addressing the potential role of EPS 
expressed by non-mucoid P. aeruginosa in protecting bacteria from the phagocytic activity 
of neutrophils or other effectors of innate immunity. In this study we show that (i) serum 
opsonins (both complement and immunoglobulin) and the Psl status are critical components 
in dictating the host innate immune response towards non-mucoid P. aeruginosa; (ii) the 
presence of Psl reduces opsonophagocytosis of P. aeruginosa by human innate immune 
cells; (iii) Psl inhibits deposition of complement component C3, C5 and C7 on the P. 
aeruginosa surface; (iv) disruption of Psl by addition of exogenous cellulase increases C3 
complement binding on the bacterial surface; (v) Psl promotes the intracellular survival of P. 
aeruginosa; and (vi) Psl-proficient bacteria have a competitive advantage over Psl-deficient 
strains in vivo.
Phagocytosis by innate immune cells is a multi-step process, which involves microbe 
recognition and ingestion by neutrophils and subsequent degradation by generating ROS and 
other digestive enzymes. The sequential production of ROS due to bacterial and neutrophil 
interaction is collectively known as an oxidative burst (Lorenzen et al., 2000; Roos et al., 
2003; Nauseef, 2007). Bacterial polysaccharides produced by B. cenocepacia and 
Staphylococcus aureus also prevent phagocytosis and killing by immune cells (Karakawa et 
al., 1988; Thakker et al., 1998; Kampen et al., 2005; Saldias et al., 2009). Our data clearly 
demonstrate that Psl reduces bacterial uptake and the oxidative burst response generated by 
neutrophils when challenged with opsonized P. aeruginosa. We also observed an enhanced 
oxidative burst response to non-opsonized Psl overexpressing strains compared with that of 
non-opsonized WT P. aeruginosa (Fig. 1C). This might be due to an interaction of Psl with 
non-opsonic receptors on neutrophils. Mannose receptors of monocyte-derived macrophages 
facilitate phagocytosis of non-opsonized P. aeruginosa (Speert et al., 1988), and Psl is 
mannose-rich (Byrd et al., 2009). Heale et al. also suggested independent involvement of 
CR3 or CD14 in non-opsonic phagocytosis of P. aeruginosa strains (Heale et al., 2001). 
Importantly, purified Psl exhibited no effect on PMA induced neutrophil burst responses in 
vitro, indicating that Psl does not likely directly inhibit neutrophil function.
Gondwe et al. showed the importance of opsonins for induction of the oxidative burst 
response of neutrophils and monocytes by invasive non-typhoidal Salmonella (Gondwe et 
al., 2010). Similarly, P. aeruginosa opsonization clearly affects the response of neutrophils 
(Fig. 1C). The results in Figs 3 and 4 also provide an explanation for the data in Fig. 1, since 
elevated opsonization of the psl mutants is expected to enhance opsonophagocytosis with a 
resultant increase in the oxidative burst response. Opsonization of bacteria requires 
deposition of activated C3b on the surface. C3b forms stable thioester bonds, leading to the 
covalent attachment of C3b with free hydroxyl or amine groups present on the surface of 
bacteria (Abdul Ajees et al., 2006). We currently favour the hypothesis that Psl functions by 
masking the accessibility of a ligand(s) present on the bacterial surface for interaction with 
C3. The identity of the P. aeruginosa surface ligand(s) to which C3 binds is not known.
Our observation that WT and psl-deficient P. aeruginosa show differential C3 deposition 
when incubated with human serum is similar to the findings of Clay et al. (2008). Their data 
provided evidence that the LPS O-antigen regulates complement C3 deposition on the 
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surface of Francisella tularensis and is a major determinant of complement activation. A 
role of O-antigen in preventing C3 deposition on Bordetella parapertussis has also been 
established (Goebel et al., 2008). Given the importance of C3 in host defence (Clay et al., 
2008; Barker et al., 2009), the inhibitory role of Psl for C3 deposition on the bacterial 
surface may provide additional protection of the pathogen in the environment of the CF lung 
and could help promote a chronic infection.
In contrast to other polysaccharides, i.e. Escherichia coli K2 capsule and the O-antigen of F. 
tularensis, which contribute to serum resistance (Clay et al., 2008; Buckles et al., 2009), Psl 
EPS does not appear to protect P. aeruginosa against complement-mediated killing. This 
could be due to several reasons. Bacterial killing by complement is associated with partial or 
complete dissolution of the outer membrane, and the molecular form of the C5-9 complex is 
crucial for optimal killing (Feingold et al., 1968a,b). Joiner et al. confirmed that multimeric 
C9 is necessary for E. coli J5 killing and that sufficient polymerization of C9 rendered 
disruption of the multilamellar detergent resistant bacterial cell wall (Joiner et al., 1985). An 
average of at least three C9 molecules is required for one C5-8 complex to kill susceptible 
cells (Joiner et al., 1985; Bloch et al., 1987). Trypanosoma cruzi amastigotes escape 
complement mediated killing because C9, while bound efficiently, is not inserted deep 
enough in the parasite lipid bilayer and fails to form pores in the membrane (Iida et al., 
1989). Therefore, the correct stoichiometric ratio of MAC complement components may be 
suboptimal for lysis of both WT and Psl-defective P. aeruginosa. Alternatively, one or more 
molecules on the bacterial surface might be inhibiting the polymerization of C9 resulting in 
protection from serum killing. Multiple factors likely contribute to preventing the effect of 
MAC-mediated killing of P. aeruginosa. While our results do not support a role for Psl in 
protection against complement-mediated killing, it is intriguing that there were significant 
differences in deposition of C3, C5 and C7 complement components on the surface of WT 
versus psl mutants. The observation that there were no apparent differences in C9 binding 
among the strains could be explained by the fact that multiple copies of C9 are normally 
found in the MAC (Kolb et al., 1972; Kondos et al., 2010), and the sensitivity of our binding 
assays may not be sufficient to resolve such differences.
Since our data suggested a protective role for Psl during interactions with neutrophils in 
vitro, we performed an in vivo acute murine pulmonary infection experiment. These results 
also revealed that Psl provides a fitness advantage to P. aeruginosa in vivo (Fig. 7). To our 
knowledge, this is a first study that addresses the impact of Psl during interaction with cells 
of the innate immune system in vivo and in vitro.
In conclusion, our results demonstrate that deletion of Psl leads to increased complement 
deposition on the bacterial surface and increased opsonophagocytosis, oxidative burst, and 
bacterial killing by neutrophils. Complement components play an important role in the 
recognition and clearance of bacteria by facilitating phagocytosis by innate immune cells. 
Using a murine model of pneumonia, Stacey et al. showed that C3 deficient mice had more 
robust P. aeruginosa colonization compared with wild-type mice (Mueller-Ortiz et al., 
2004). The reduction of CI at 12 h post infection in our in vivo model could suggest that Psl 
is important for adaptation to host conditions that exist later in infection. This may be one 
mechanism by which non-mucoid P. aeruginosa persists during lung infection in CF 
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patients even in the presence of a robust neutrophil response (Fig. 7). The psl operon appears 
to be highly conserved in clinical and environmental isolates of P. aeruginosa (Wolfgang et 
al., 2003; Jackson et al., 2004). Given the importance of Psl in colonization, biofilm 
formation and avoidance of host defence mechanisms, Psl may represent a therapeutic target 
for prevention of persistent P. aeruginosa infection in CF patients.
Experimental procedures
Strains and growth media
Wild-type P. aeruginosa (PAO1), Psl-deficient P. aeruginosa WFPA800 (Δpsl), the 
arabinose-inducible Psl overexpressing strain WFPA801 (Ma et al., 2006), a streptomycin 
resistant variant of PAO1 (Jackson et al., 2004), and the O-antigen deficient strain of P. 
aeruginosa (ΔwaaL) (Abeyrathne et al., 2005), were grown in Luria–Bertani (LB) without 
NaCl (LBNS). Arabinose was added to WFPA801 for induction of Psl (2% w/v final 
concentration) and also included in the WT (PAO1) and Psl-deficient (WFPA800) culture as 
a control. No antibiotic selection was used for routine growth of these strains.
Neutrophil isolation and oxidative burst studies
Human neutrophils and serum were obtained from healthy adult donors using an approved 
IRB protocol (2009H0314) at The Ohio State University. Heparinized blood was placed on a 
Ficoll Hypaque density cushion (Amersham Biosciences), centrifuged at 400 g and the 
resultant RBC-rich pellet was resuspended 1:1 in normal saline. To obtain a leucocyte-rich 
supernatant, RBCs were allowed to sediment in the presence of 1.5% dextran at 4°C for 30 
min. The supernatant was gently removed and centrifuged at 550 g for 10 min at 4°C. 
Pelleted RBCs were subjected to hypotonic lysis with 10 ml of distilled water and the 
isotonicity was restored by the addition of an equal amount of 1.8% NaCl. Neutrophils were 
resuspended in Hank’s buffered salt solution (HBSS), counted on a haemocytometer, and 
kept on ice for use.
The luminol chemiluminescence assay was used to detect intracellular and extracellular 
ROS generated by neutrophils upon interaction with P. aeruginosa (Engels et al., 1985). WT 
P. aeruginosa, Δpsl and Psl-overexpressing bacterial suspensions were opsonized with 10% 
fresh human serum at 37°C for 30 min, washed and compared for generation of the ROS 
response by neutrophils. PMA (10 ng) was used as a positive control for generation of the 
ROS by neutrophils. Neutrophils (2 × 105) were seeded on a 96-well microtitre plate and a 
bacterial suspension of mid-log phase culture was added (moi of 50 bacteria to 1 neutrophil) 
to the wells in the presence of 50 μM of luminol. The microtitre plate was centrifuged at 100 
g for 2 min at 12°C to synchronize the infection. The relative amount of ROS generated by 
neutrophils was detected at regular intervals over 72 min by measuring the luminescence. 
Relative light units (RLU) were plotted as a function of time to evaluate chemiluminescence 
(CL) rate (Mohapatra et al., 2010). The DCF assay for detecting the respiratory burst was 
performed as outlined elsewhere (Crowther et al., 2004). Psl was purified according to Byrd 
et al. (2009) and 500 μg or 1 mg was used to study the oxidative burst response by PMA-
activated neutrophils.
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Complement component deposition and bacterial killing
Methods by Balagopal et al. (2006) were used to harvest fresh complement sufficient serum. 
Mid-log phase grown bacteria were opsonized with 20% fresh human serum at 37°C for 5 
and 20 min, and reactions stopped by the addition of 10 mM EDTA and incubation on ice. 
Bacteria were washed, fixed and stained using anti-human C3 (Quidel), C5, C7 or C9 
polyclonal antibodies (Complement Tech.) at a 1:1000 dilution. Following incubation, 
samples were washed and detected using Alexa Fluor 647-conjugated secondary antibody 
(Invitrogen) at a 1:500 dilution. After final washes, the pelleted bacteria were analysed by 
flow cytometry (FACS Calibur; BD Biosciences) for quantification of complement 
deposition on the bacterial surface. Non-opsonized bacteria were used in each experiment to 
set the gate for analysis. Data from 30 000-gated events were collected and the percentage of 
fluorescence (percentage positive cells) was calculated for each sample. For the bacterial 
killing assays, mid-log phase WT, Δpsl, Psl-overexpressing and ΔwaaL strains of P. 
aeruginosa were opsonized with PBS or 20% and 50% pooled normal human serum 
(Complement Tech.) for 30 min at 37°C with slow agitation. The tubes were placed on ice 
for 5 min to stop the reaction, bacteria were washed extensively, and 10-fold serial dilutions 
were plated to determine surviving colony-forming units (cfu).
Electron microscopy
Mid-log phase grown bacteria were opsonized with 20% pooled human serum (Complement 
Tech.) at 37°C for 20 min. Reactions were stopped by adding 10 mM EDTA, bacteria were 
washed, fixed, blocked and stained with anti-human C3 antibody (1:500 dilution) for 1 h. 
Following incubation, samples were washed and counter stained with 15 nm colloidal gold 
labelled rabbit anti-goat antibody (Abcam) at a dilution of 1:500 for 1 h. Labelled samples 
were washed, fixed and embedded in Eponate 12 resin, followed by sectioned on a Leica 
EMU 6 ultramicrotome. Sections were collected onto grids and viewed by transmission 
electron microscopy (FEI Tecnai G2 Spirit) operating at 80 kV. Images in Fig. 3B are 
representative of cells in two independent experiments. For quantification of C3 binding, 
100 random bacterial cells were evaluated in two independent experiments.
Bacterial uptake by neutrophils
Neutrophils (2 × 105 per well) were seeded on poly-L-lysine coated coverslips and mid-log 
phase P. aeruginosa, opsonized with 20% human serum, were added at an moi (bacteria : 
neutrophil) of 10:1, 5:1 and 3:1 onto the neutrophil monolayers in the appropriate 
experiment. The mixture was incubated for 30 min at 37°C, 5% CO2. Cells were washed 
extensively with HBSS to remove non-adherent bacteria, fixed and stained with anti-
Pseudomonas antibody (diluted to 1:1000) before and after cell membrane permeabilization 
with methanol (Balagopal et al., 2006). The anti-Pseudomonas antibody was generated 
against whole surface antigens of strain PAO1. Visualization of bacteria–phagocyte 
association by confocal microscopy (Olympus FV 1000) using 60× oil objective allowed us 
to differentiate attached P. aeruginosa from internalized bacteria. Attached bacteria exposed 
to the antibodies before permeabilization stain green due to counter staining with Alexa 
Fluor 488 (diluted to 1:500), while internalized bacteria exposed to the antibodies after 
permeabilization stain red due to Alexa Fluor 647 as a secondary stain (diluted to 1:500). 
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For quantification, 100 neutrophils were chosen at random and the cell-associated versus 
internalized bacteria counted and averaged by two readers blinded to the treatment 
conditions. Bacterial uptake was also studied in THP-1-derived macrophages by growing 
THP-1 cells in RPMI supplemented with 10% FBS. Cultured THP-1 cells were stimulated 
with 100 nM PMA for 36 h prior to the addition of bacterial suspension. The resultant 
THP-1 derived macrophages were incubated with bacteria for 90 min and bacterial 
attachment and internalization were analysed as above.
P. aeruginosa-neutrophil killing assay
Neutrophils (2 × 105) were seeded onto poly-L-lysine coated 24-well plates in HBSS, and 
mid-log phase cultures of bacteria were added at an moi of 100:1. To normalize the uptake 
of bacteria by neutrophil, this experiment was also performed with reduced moi of psl-
deficient P. aeruginosa (30:1). After a 30 min incubation, neutrophils were washed 
vigorously and treated with 150 μg ml−1 gentamicin for 30 min at 37°C in 5% CO2 to kill 
extracellular and attached bacteria. Samples were washed and lysed with 0.1% Triton X-100 
for 2 min immediately prior to plating for cfu. The percentage of killed bacteria was 
calculated relative to the total number of cell-associated bacteria. To estimate the total 
number of associated bacteria, wells were not treated with gentamicin.
Cellulase treatment
Mid-log phase bacteria were incubated with 10 mg ml−1 cellulase (1.38 unit per mg, Sigma) 
in PBS for 20 h at 37°C. After extensive washing with PBS bacteria were opsonized with 
20% normal human pooled serum and C3 deposition on the bacterial surface was evaluated 
at both 5 min and 30 min time points as above.
In vivo mixed infection competition
All experimental animals were handled in accordance with OSU institutional guidelines 
(IACUC approval number 2009A0177). P. aeruginosa strains grown to OD600 = 0.5 at 
37°C, harvested by centrifugation, washed with PBS, and diluted to an estimated 
concentration of 1 × 108 bacteria in 30 μl. Groups of 5 female C57BL/6 mice were mildly 
sedated by isoflurane inhalation and infected intranasally with ~ 1 × 108 total bacteria of a 
1:1 mixture of streptomycin resistant P. aeruginosa PAO1 and its isogenic psl-deficient 
strain. A parallel control group received the same inoculum of PBS. At 4 and 12 h post 
infection, five mice from each group were euthanized and lung homogenates plated in the 
presence and absence of streptomycin for differential enumeration of bacterial strains. The 
CI was calculated by dividing the ratio of the amount of psl-deficient bacteria recovered by 
the amount of PAO1 Smr recovered (CI values < 1 indicate a competitive advantage of the 
WT strain). An in vitro growth competition experiment with co-culturing PAO1 Smr and 
WFPA800 did not show a growth advantage for either strain or a CI value of 1.0.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Serum opsonization of a Psl-deficient mutant of P. aeruginosa increases the oxidative burst 
by human neutrophils. A. Immunoblot showing expression of Psl from EPS extracts derived 
from strains PAO1, WFPA800 and WFPA801 (Byrd et al., 2009). These extracts were 
blotted on a nitrocellulose membrane, probed with anti-Psl antiserum and detected by 
chemiluminescence using a HRP-conjugated secondary antibody. B. Kinetic analysis of the 
chemiluminescence response (measurement of oxidative burst) of neutrophils generated 
against pre-opsonized Psl variant strains of P. aeruginosa. Each experiment was performed 
in quadruplet wells (n = 3 with 10% fresh normal human serum opsonization). RLU, relative 
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luminescence unit. C. Oxidative burst response of neutrophils induced by Psl variant strains 
of P. aeruginosa under fresh serum opsonized (NHS), heat-inactivated serum (HIS)-
opsonized and non-opsonized conditions. Bacteria were incubated with serum or no serum, 
washed and then incubated with neutrophils (moi 50:1) at 37°C for 25 min in presence of 
luminol and the chemiluminescence response of neutrophils was measured. Each experiment 
was performed in quadruplet wells (n = 5 for 10% NHS opsonization, HIS opsonization and 
non-opsonization). Values are mean ± SEM for five experiments. A statistical analysis was 
carried out using an unpaired two-tailed student’s t-test to compare the chemiluminescence 
response of neutrophils induced by HIS, opsonized and unopsonized bacteria. The asterisks 
indicate P-values (*P ≤ 0.05; **P ≤ 0.005). RLU, relative luminescence unit.
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The presence of Psl reduces the uptake of P. aeruginosa by human phagocytic cells. 
Immunofluorescence images of (A) THP-1 cells and (B) human neutrophils, infected with 
pre-opsonized WT or a psl-deficient strain of P. aeruginosa. Bacteria were incubated with 
neutrophils at an moi of 5:1 and processed as described in Experimental procedures. 
Attached bacteria exposed to the antibodies before permeabilization stained green. Those 
exposed to the antibodies only after permeabilization stained red (internalized bacteria). 
Blue (DAPI) fluorescence was used to stain the nuclei of THP-1 cells and neutrophils (60× 
oil objective). Arrows indicate the internalized bacteria in the PAO1 samples. Scale bar is 
equal to 10 μm. The number (mean ± SD) of internalized bacteria is indicated in parentheses 
and is representative of 100 infected cells (neutrophils and macrophages) examined from 
triplicate coverslips.
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Increased C3 complement component deposition on psl-deficient P. aeruginosa. A total of 2 
× 108 mid-log phase bacteria were opsonized with 20% fresh human serum at 37°C for 5 or 
20 min, followed by the addition of 10 mM EDTA to stop the reaction. Bacteria were fixed 
and stained with anti-human C3 antibody (A) counter stained with fluorescent antibody and 
analysed by flow cytometry (B) counter stained with 15-nm colloidal gold rabbit anti-goat 
antibody and analysed by transmission electron microscopy (TEM), as outlined in 
Experimental procedures. Bar represents 500 nm. Arrows indicate the C3 complement 
deposition on the bacterial surface. The number in parentheses (mean ± SD) indicated 
deposition of C3 complement component on individual bacteria (averaged from 100 
bacterial cells evaluated). Statistical analysis was carried out using the unpaired two-tailed 
Student’s t-test to compare the deposition of C3 complement component on the surface of 
the psl-deficient strain with WT and the Psl++ strains of P. aeruginosa. Mean ± SEM are 
given (n = 3). The asterisks indicate P-values (*P ≤ 0.05; **P ≤ 0.005; ***P ≤ 0.0005).
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Psl limits C5 and C7 complement component deposition on P. aeruginosa. A total of 2 × 
108 mid-log phase bacteria were opsonized with 20% fresh human serum at 37°C for 5 and 
20 min, followed by the addition of 10 mM EDTA to stop the reaction. Bacteria were fixed 
and stained with (A) anti-human C5 antibody and (B) anti-human C7 antibody as outlined in 
Experimental procedures. Mean ± SEM are given (n = 3). Statistical analysis was carried 
out using the unpaired two-tailed Student’s t-test to compare the deposition of C3 
complement component on the surface of the psl-deficient strain with WT and the Psl++ 
strains of P. aeruginosa. The asterisks indicate P-values (**P ≤ 0.005; ***P ≤ 0.0005).
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Psl polysaccharide has no effect on C9 deposition and complement-mediated killing.
A. C9 complement component deposition was measured on WT, psl-deficient and Psl 
overexpressing strains of P. aeruginosa. Results are expressed as percentage of fluorescence 
positive cells as in Fig. 4, which is indicative of complement deposition on the bacterial 
surface. The experiment shown is representative of three independent experiments 
performed in triplicate. Data are mean ± SEM.
B. Sensitivity of WT, psl-deficient and Psl overexpressing strains of P. aeruginosa to 
complement-mediated killing in the presence of 0, 20 and 50 percent fresh normal human 
serum (NHS). Bacterial survival is expressed as the percentage of bacteria recovered from 
the initial inoculation amount (incubated with buffer only without serum), which is set at 
100%. Data represent mean ± SEM from a representative experiment (n = 3).
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Psl enhances intracellular survival of P. aeruginosa in human neutrophils.
A. Opsonized WT PAO1 and psl-deficient P. aeruginosa were incubated with 2 × 105 
human neutrophils at the indicated moi for 30 min. Extracellular and attached bacteria were 
killed by treatment with gentamicin, then neutrophils were lysed with 0.1% Triton X-100 
and lysates plated to enumerate viable bacteria. Results are expressed as the percentage of 
bacteria that survived relative to total cell-associated bacteria and are representative of three 
independent experiments performed in triplicate. Bars represent mean ± SEM. Statistical 
analysis was carried out using the unpaired two-tailed Student’st-test. The asterisks indicate 
P-values (**P ≤ 0.005; ***P ≤ 0.0005).
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B. Immunofluorescence images (60× oil objective) showing equal uptake of bacteria 
(stained red) by neutrophils when the moi of WT and psl-deficient bacteria were adjusted. 
The moi and number of internalized bacteria (mean ± SD) per 100 neutrophils are indicated. 
Colours indicate: green, attached bacteria; red, internalized bacteria; blue, neutrophil 
nucleus. Scale bar represent 10 μm.
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The presence of Psl provides a fitness advantage for P. aeruginosa during an acute murine 
pulmonary infection. Six-week-old female C57BL/6 mice were co-infected at a 1:1 ratio 
(total of 108 bacteria) with psl mutant and WT streptomycin resistant P. aeruginosa strains. 
Bacteria were harvested from the lungs at 4 and 12 h post infection. Viable cell counts and 
the competitive index (CI) of the two strains were determined as outlined in the 
Experimental procedures. Dashed line represents a CI of 1.0 (no advantage for WT or psl 
mutants).
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